These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 9620709)
1. Are angiostatin and endostatin cures for cancer? Harris AL Lancet; 1998 May; 351(9116):1598-9. PubMed ID: 9620709 [No Abstract] [Full Text] [Related]
2. [Angiostatin. A biological inhibitor of tumor angiogenesis]. Thimme R; Spangenberg HC; Blum HE Dtsch Med Wochenschr; 1997 Mar; 122(13):413-4. PubMed ID: 9138915 [No Abstract] [Full Text] [Related]
3. [Antiangiogenic therapy]. Toi M Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900 [TBL] [Abstract][Full Text] [Related]
4. Cancer 'cure' article stirs up hot debate. Wadman M Nature; 1998 May; 393(6681):104-5. PubMed ID: 9603508 [No Abstract] [Full Text] [Related]
5. Angiostatin and endostatin: endogenous inhibitors of tumor growth. Sim BK; MacDonald NJ; Gubish ER Cancer Metastasis Rev; 2000; 19(1-2):181-90. PubMed ID: 11191058 [TBL] [Abstract][Full Text] [Related]
6. A new approach to fighting cancer? Sato TN Proc Natl Acad Sci U S A; 1998 May; 95(11):5843-4. PubMed ID: 9600880 [No Abstract] [Full Text] [Related]
7. Cancer experts offer healthy dose of skepticism toward hype over antiangiogenesis agents. Phillips P JAMA; 1998 Jun; 279(24):1936-7. PubMed ID: 9643843 [No Abstract] [Full Text] [Related]
9. [Tumor angiogenesis inhibitors: media and scientific aspects]. Raymond E Presse Med; 1998 Jul 4-11; 27(24):1221-4. PubMed ID: 9767782 [TBL] [Abstract][Full Text] [Related]
10. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Yokoyama Y; Dhanabal M; Griffioen AW; Sukhatme VP; Ramakrishnan S Cancer Res; 2000 Apr; 60(8):2190-6. PubMed ID: 10786683 [TBL] [Abstract][Full Text] [Related]
11. [The clinical perspective of angiogenesis inhibitors]. Radema SA; Witteveen PO; Gebbink MB; Voest EE Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538 [TBL] [Abstract][Full Text] [Related]
12. Angiogenesis: the unifying concept in cancer? Saphir A J Natl Cancer Inst; 1997 Nov; 89(22):1658-9. PubMed ID: 9390530 [No Abstract] [Full Text] [Related]
13. Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment. Hayes AJ; Li LY; Lippman ME BMJ; 1999 Mar; 318(7187):853-6. PubMed ID: 10092266 [No Abstract] [Full Text] [Related]
14. [Neovascularization and tumor development]. Ono M; Kuwano M Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1577-87. PubMed ID: 9780690 [No Abstract] [Full Text] [Related]
15. Adeno-associated virus and other potential vectors for angiostatin and endostatin gene therapy. Nguyen JT Adv Exp Med Biol; 2000; 465():457-66. PubMed ID: 10810649 [No Abstract] [Full Text] [Related]
16. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors. Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903 [TBL] [Abstract][Full Text] [Related]
17. [Endostatin and angiostatin: two weapons, a single target]. Lopez M Clin Ter; 1998; 149(2):95-8. PubMed ID: 9780471 [No Abstract] [Full Text] [Related]
18. Cancer "breakthrough" is still in the future. Health News; 1998 Jun; 4(7):6. PubMed ID: 9624918 [No Abstract] [Full Text] [Related]
19. A cancer therapy resistant to resistance. Kerbel RS Nature; 1997 Nov; 390(6658):335-6. PubMed ID: 9389468 [No Abstract] [Full Text] [Related]
20. The promise of anti-angiogenic cancer therapy. Oehler MK; Bicknell R Br J Cancer; 2000 Feb; 82(4):749-52. PubMed ID: 10732738 [No Abstract] [Full Text] [Related] [Next] [New Search]